Home › Asset managers › Aberdeen › 2024-2025 › Against the board
Two kinds of vote are listed: a board-sponsored proposal Aberdeen voted AGAINST or withheld on, and a shareholder proposal it voted FOR. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
1,606 proposals.
| Company | Meeting | Proposal | Category | On the ballot from | Aberdeen voted | Funds |
|---|---|---|---|---|---|---|
| Simon Property Group, Inc. | 2025-05-14 | Ratify the appointment of Ernst & Young LLP as our Independent Registered Public Accounting Firm for 2025. | Audit-related | Board | AGAINST | 2 |
| Snowflake Inc. | 2024-07-02 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 2 |
| Sociedad Quimica y Minera de Chile SA | 2025-04-24 | Approve Remuneration of Board of Directors and Board Committees | Compensation | Board | AGAINST | 2 |
| Sociedad Quimica y Minera de Chile SA | 2025-04-24 | Designate Account Inspectors | Compensation | Board | ABSTAIN | 2 |
| Summit Therapeutics Inc. | 2025-06-12 | ELECTION OF DIRECTORS: Kenneth A. Clark | Director Elections | Board | AGAINST | 2 |
| Summit Therapeutics Inc. | 2025-06-12 | ELECTION OF DIRECTORS: Yu (Michelle) Xia | Director Elections | Board | AGAINST | 2 |
| Sun Communities, Inc. | 2025-05-13 | To ratify the selection of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. | Audit-related | Board | AGAINST | 2 |
| Syndax Pharmaceuticals, Inc. | 2025-05-14 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2025 proxy statement. | Say-on-Pay | Board | AGAINST | 2 |
| TScan Therapeutics, Inc. | 2025-06-30 | To elect three Class I directors to the Company's Board of Directors: Garry Nicholson | Director Elections | Board | WITHHOLD | 2 |
| Tarsus Pharmaceuticals, Inc. | 2025-06-12 | To hold an advisory vote to approve, on a non-binding basis, named executive officer compensation. | Say-on-Pay | Board | AGAINST | 2 |
| Tempus AI, Inc. | 2025-05-20 | To approve the reincorporation of the Company from the State of Delaware to the State of Nevada by conversion. | Extraordinary Transactions | Board | AGAINST | 2 |
| Tempus AI, Inc. | 2025-05-20 | To elect nine directors to serve until the next annual meeting and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Eric Lefkofsky | Director Elections | Board | WITHHOLD | 2 |
| Tenet Healthcare Corporation | 2025-05-22 | Election of Directors: J. Robert Kerrey | Director Elections | Board | AGAINST | 2 |
| Tetra Tech, Inc. | 2025-02-27 | To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for fiscal year 2025. | Audit-related | Board | AGAINST | 2 |
| Texas Pacific Land Corporation | 2024-11-08 | To approve, by non-binding advisory vote, the executive compensation paid to the Company's named executive officers. | Say-on-Pay | Board | AGAINST | 2 |
| The Carlyle Group Inc. | 2025-05-29 | Non-Binding Vote to Approve Named Executive Officer Compensation ("Say-on-Pay") | Say-on-Pay | Board | AGAINST | 2 |
| The Trade Desk, Inc. | 2025-05-27 | The approval, on a non-binding, advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 2 |
| The Vita Coco Company, Inc. | 2025-06-03 | Election of Class I Directors: Aishetu Fatima Dozie | Director Elections | Board | WITHHOLD | 2 |
| Trex Company, Inc. | 2025-05-06 | Non-binding advisory vote on executive compensation ("say-on-pay") | Say-on-Pay | Board | AGAINST | 2 |
| Twilio Inc. | 2025-06-10 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 2 |
| Ultragenyx Pharmaceutical Inc. | 2025-05-15 | Approval of the Second Amended and Restated 2023 Incentive Plan. | Compensation | Board | AGAINST | 2 |
| Union Pacific Corporation | 2025-05-08 | Election of Directors: Michael R. McCarthy | Director Elections | Board | AGAINST | 2 |
| Union Pacific Corporation | 2025-05-08 | Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for 2025. | Audit-related | Board | AGAINST | 2 |
| Universal Health Realty Income Trust | 2025-06-11 | Proposal to ratify the selection of KPMG, LLP as the Trust's independent registered public accounting firm for the fiscal year ending December 31, 2025. | Audit-related | Board | AGAINST | 2 |
| VINCI SA | 2025-04-17 | Approve Issuance of Equity or Equity-Linked Securities for Private Placements, up to Aggregate Nominal Amount of EUR 150 Million | Capital Structure | Board | AGAINST | 2 |
| VINCI SA | 2025-04-17 | Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Under Items 20, 21, and 22 | Capital Structure | Board | AGAINST | 2 |
| VINCI SA | 2025-04-17 | Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to Aggregate Nominal Amount of EUR 150 Million | Capital Structure | Board | AGAINST | 2 |
| VINCI SA | 2025-04-17 | Authorize up to 1 Percent of Issued Capital for Use in Restricted Stock Plans Reserved for Employees with Performance Conditions Attached | Compensation | Board | AGAINST | 2 |
| VINCI SA | 2025-04-17 | Reelect Yannick Assouad as Director | Director Elections | Board | AGAINST | 2 |
| Vaxcyte, Inc. | 2025-06-12 | Election of Class II Directors Nominees would serve until the 2028 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: John Furey | Director Elections | Board | WITHHOLD | 2 |
| Verint Systems Inc. | 2024-07-10 | Advisory vote to approve the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 2 |
| Verona Pharma Plc | 2025-04-24 | To authorize the Board of Directors to allot equity securities for cash and/or to sell ordinary shares held by the Company as treasury shares for cash as if section 561(1) of the Companies Act does not apply to any such allotment. | Capital Structure | Board | AGAINST | 2 |
| Verona Pharma Plc | 2025-04-24 | To receive and approve, as a non-binding advisory resolution, the U.K. statutory Directors' Remuneration Report for the year ended December 31, 2024. | Compensation | Board | AGAINST | 2 |
| Vertex Pharmaceuticals Incorporated | 2025-05-14 | Election of Directors: Bruce Sachs | Director Elections | Board | AGAINST | 2 |
| Vertex Pharmaceuticals Incorporated | 2025-05-14 | Ratification of Ernst & Young LLP as independent Registered Public Accounting firm for the year ending December 31, 2025. | Audit-related | Board | AGAINST | 2 |
| Vertex, Inc. | 2025-06-11 | Election of directors: J. Richard Stamm | Director Elections | Board | WITHHOLD | 2 |
| Vertex, Inc. | 2025-06-11 | Election of directors: Philip Saunders | Director Elections | Board | WITHHOLD | 2 |
| WSFS Financial Corporation | 2025-05-15 | The ratification of the appointment of KPMG LLP as WSFS Financial Corporation's independent registered public accounting firm for the fiscal year ending December 31, 2025. | Audit-related | Board | AGAINST | 2 |
| Watsco, Inc. | 2025-06-02 | Approval of the advisory resolution regarding the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 2 |
| Werner Enterprises, Inc. | 2025-05-13 | To approve an advisory resolution on executive compensation. | Say-on-Pay | Board | AGAINST | 2 |
| Williams-Sonoma, Inc. | 2025-06-11 | An advisory vote to approve executive compensation | Say-on-Pay | Board | AGAINST | 2 |
| Wintrust Financial Corporation | 2025-05-22 | Election of Directors: H. Patrick Hackett, Jr. | Director Elections | Board | AGAINST | 2 |
| Wintrust Financial Corporation | 2025-05-22 | Election of Directors: Peter D. Crist | Director Elections | Board | AGAINST | 2 |
| Wintrust Financial Corporation | 2025-05-22 | Proposal to ratify the appointment of Ernst & Young LLP to serve as the independent registered public accounting firm for fiscal year 2025. | Audit-related | Board | AGAINST | 2 |
| Workiva Inc. | 2025-05-29 | Election of Directors: Martin J. Vanderploeg, Ph.D. | Director Elections | Board | WITHHOLD | 2 |
| Workiva Inc. | 2025-05-29 | Election of Directors: Suku Radia | Director Elections | Board | WITHHOLD | 2 |
| Xencor, Inc. | 2025-06-12 | To approve the proposed amendment and restatement of the Company's 2023 Equity Incentive Plan to increase the number of authorized shares reserved for issuance thereunder by 3,000,000 shares; | Compensation | Board | AGAINST | 2 |
| Yifeng Pharmacy Chain Co., Ltd. | 2025-05-29 | Approve Provision of Guarantee | Capital Structure | Board | AGAINST | 2 |
| Yifeng Pharmacy Chain Co., Ltd. | 2025-05-29 | Approve Use of Idle Own Funds for Entrusted Financial Management | Extraordinary Transactions | Board | AGAINST | 2 |
| Zai Lab Limited | 2025-06-18 | THAT, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement, is hereby approved. | Say-on-Pay | Board | AGAINST | 2 |
| Zoom Communications, Inc. | 2025-06-12 | Approve, on an advisory non-binding basis, the compensation of our named executive officers as disclosed in our proxy statement. | Say-on-Pay | Board | AGAINST | 2 |
| Zscaler, Inc. | 2025-01-10 | To approve on a non-binding, advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 2 |
| Zurn Elkay Water Solutions Corporation | 2025-05-01 | Advisory vote to approve the compensation of Zurn Elkay's named executive officers, as disclosed in "Compensation Discussion and Analysis" and "Executive Compensation" in the Proxy Statement. | Say-on-Pay | Board | AGAINST | 2 |
| lululemon athletica inc. | 2025-06-11 | To approve, on an advisory basis, the compensation of the Company's named executive officers. | Say-on-Pay | Board | AGAINST | 2 |
| ADNOC Drilling Co. PJSC | 2025-03-17 | Discuss and Approve Remuneration of Directors for FY 2024 | Compensation | Board | ABSTAIN | 1 |
| AECOM | 2025-02-28 | Advisory vote to approve the Company's executive compensation. | Say-on-Pay | Board | AGAINST | 1 |
| ALS LTD. | 2024-07-31 | Approve the Spill Resolution | Compensation | Board | AGAINST | 1 |
| ALS Limited | 2024-07-31 | Approve the Spill Resolution | Compensation | Board | AGAINST | 1 |
| ALX Oncology Holdings Inc. | 2025-06-11 | Election of Directors: Scott Garland | Director Elections | Board | WITHHOLD | 1 |
| ANA HOLDINGS INC. | 2025-06-27 | Elect Director Yamamoto, Ado | Director Elections | Board | AGAINST | 1 |
| ARCA biopharma, Inc. | 2024-08-22 | To approve the Oruka Therapeutics, Inc. 2024 Employee Stock Purchase Plan; | Compensation | Board | AGAINST | 1 |
| ARCA biopharma, Inc. | 2024-08-22 | To approve the Oruka Therapeutics, Inc. 2024 Stock Incentive Plan; | Compensation | Board | AGAINST | 1 |
| ARCA biopharma, Inc. | 2024-08-22 | To elect the Class III director, Jacob Ma-Weaver, to ARCA's board of directors and to hold office until ARCA's 2027 annual meeting of stockholders and until his successor has been duly elected and qualified, or until his earlier death, resignation or removal, provided that if the Merger is consummated, the approval of Proposal No. 5 will only have an effect until the completion of the Merger because the composition of ARCA's board of directors will be reconstituted upon completion of the Merger, in accordance with the Merger Agreement; | Director Elections | Board | WITHHOLD | 1 |
| ARISTOCRAT LEISURE LTD. | 2025-02-20 | Approve Grant of Performance Share Rights to Trevor Croker Under the Long-Term Incentive Plan | Compensation | Board | AGAINST | 1 |
| ARISTOCRAT LEISURE LTD. | 2025-02-20 | Approve Remuneration Report | Compensation | Board | AGAINST | 1 |
| AUB GROUP LTD. | 2024-10-31 | Elect Stephen Mayne as Director | Director Elections | Board | AGAINST | 1 |
| Abeona Therapeutics Inc. | 2025-05-19 | Election of three Class 3 Directors for a three-year term: Mark J. Alvino | Director Elections | Board | AGAINST | 1 |
| Abivax SA | 2025-06-06 | Approve Compensation Report | Compensation | Board | AGAINST | 1 |
| Abivax SA | 2025-06-06 | Approve Compensation Report of Corporate Officers | Compensation | Board | AGAINST | 1 |
| Abivax SA | 2025-06-06 | Approve Issuance of Equity or Equity-Linked Securities Reserved for Specific Beneficiaries, up to Aggregate Nominal Amount of EUR 750,000 | Capital Structure | Board | AGAINST | 1 |
| Abivax SA | 2025-06-06 | Approve Issuance of Equity or Equity-Linked Securities for Qualified Investors, up to Aggregate Nominal Amount of EUR 223,822 | Capital Structure | Board | AGAINST | 1 |
| Abivax SA | 2025-06-06 | Approve Issuance of Warrants (Bons) Reserved for Services Providers, Consultants, Employees and Executives, up to 10 Percent of Issued Share Capital | Compensation | Board | AGAINST | 1 |
| Abivax SA | 2025-06-06 | Approve Remuneration Policy of CEO | Compensation | Board | AGAINST | 1 |
| Abivax SA | 2025-06-06 | Approve Remuneration Policy of Chairman of the Board | Compensation | Board | AGAINST | 1 |
| Abivax SA | 2025-06-06 | Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Above | Capital Structure | Board | AGAINST | 1 |
| Abivax SA | 2025-06-06 | Authorize Capital Increase of Up to EUR 750,000 for Future Exchange Offers | Capital Structure | Board | AGAINST | 1 |
| Abivax SA | 2025-06-06 | Authorize Capital Increase of up to 20 Percent of Issued Capital for Contributions in Kind | Capital Structure | Board | AGAINST | 1 |
| Abivax SA | 2025-06-06 | Authorize Issuance of Equity or Equity-Linked Securities with Preemptive Rights up to Aggregate Nominal Amount of EUR 750,000 | Capital Structure | Board | AGAINST | 1 |
| Abivax SA | 2025-06-06 | Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to Aggregate Nominal Amount of EUR 750,000 | Capital Structure | Board | AGAINST | 1 |
| Abivax SA | 2025-06-06 | Authorize Repurchase of Up to 10 Percent of Issued Share Capital | Capital Structure | Board | AGAINST | 1 |
| Abivax SA | 2025-06-06 | Authorize up to 10 Percent of Issued Capital for Use in Restricted Stock Plans | Compensation | Board | AGAINST | 1 |
| Abivax SA | 2025-06-06 | Authorize up to 10 Percent of Issued Capital for Use in Stock Option Plans | Compensation | Board | AGAINST | 1 |
| Abivax SA | 2025-06-06 | Ratify Appointment of Dominik Hochli as Director | Director Elections | Board | AGAINST | 1 |
| Abivax SA | 2025-06-06 | Ratify Appointment of Sylvie Gregoire as Director | Director Elections | Board | AGAINST | 1 |
| Abivax SA | 2025-06-06 | Reelect Camilla Soenderby as Director | Director Elections | Board | AGAINST | 1 |
| Abivax SA | 2025-06-06 | Reelect Corinna zur Bonsen-Thomas as Director | Director Elections | Board | AGAINST | 1 |
| Abivax SA | 2025-06-06 | Reelect Dominik Hochli as Director | Director Elections | Board | AGAINST | 1 |
| Addtech AB | 2024-08-22 | Approve Remuneration Report | Compensation | Board | AGAINST | 1 |
| Addtech AB | 2024-08-22 | Elect Fredrik Borjesson as New Director | Director Elections | Board | AGAINST | 1 |
| Addtech AB | 2024-08-22 | Reelect Henrik Hedelius as Director | Director Elections | Board | AGAINST | 1 |
| Addtech AB | 2024-08-22 | Reelect Ulf Mattson as Director | Director Elections | Board | AGAINST | 1 |
| Adobe Inc. | 2025-04-22 | Ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending on November 28, 2025. | Audit-related | Board | AGAINST | 1 |
| Affimed NV | 2024-10-10 | Approve Addendum to the Remuneration Policy for the Management Board in Respect of Shawn Leland | Compensation | Board | AGAINST | 1 |
| Agree Realty Corporation | 2025-05-15 | To approve, by non-binding vote, executive compensation. | Say-on-Pay | Board | AGAINST | 1 |
| Air Astana JSC | 2024-11-15 | Amend Large-Scale Related-Party Transaction with International Aero Engines LLC and FlyArystan JSC | Extraordinary Transactions | Board | AGAINST | 1 |
| Albertsons Companies, Inc. | 2024-08-08 | Hold the annual, non-binding, advisory vote on our executive compensation program. | Say-on-Pay | Board | AGAINST | 1 |
| Alexander & Baldwin, Inc. | 2025-04-22 | Approve the advisory resolution relating to executive compensation | Say-on-Pay | Board | AGAINST | 1 |
| Allogene Therapeutics, Inc. | 2025-06-18 | Election of Directors: Arie Belldegrun, M.D. | Director Elections | Board | WITHHOLD | 1 |
| Allogene Therapeutics, Inc. | 2025-06-18 | Election of Directors: Elizabeth Barrett | Director Elections | Board | WITHHOLD | 1 |
| Alphatec Holdings, Inc. | 2025-06-11 | Approval of an amendment to our 2016 Equity Incentive Plan. | Compensation | Board | AGAINST | 1 |
← Previous Page 11 of 17 Next →
← Back to Aberdeen 2024-2025 overview
Built 2026-10-11 from SEC Form N-PX filings.